- Home/In The News/Blog/2013/December
20
December2013
category:
503b CompoundingNovartis Recalls About 5.3 Million Bottles of Sample Drugs
Novartis NOVN.VX in Your Value Your Change Short position has recalled about 5.3 million bottles of blood-pressure medications and other drugs that were provided as free samples to U.S. physicians’ offices, citing potential contamination by a packaging chemical. The bulk of the voluntary recall, which was initiated in the summer, was for about 4.7 million […]
read more20
December2013
category:
503b CompoundingAbrams Royal compounding pharmacy recalls all sterile products after adverse event, FDA reports: Food and Drug recalls
CLEVELAND, Ohio– Abrams Royal Compounding Pharmacy, a Dallas-based pharmaceutical product supplier, is recalling all of its unexpired sterile products after an adverse event related to their use, according to a Food and Drug Administration news release. The products include injectable medications, IVs, eye drops, pellet implants, nasal sprays, inhalation solutions and eye ointments, and were […]
read more20
December2013
category:
503b CompoundingDrug Shortage Helps Lead to Fall in 2013 Executions
The long-running controversy over lethal-injection drugs helped push the number of executions in 2013 down by about 10%, according to a new report published Thursday. In 2013, nine states were responsible for 39 executions, four fewer than the 43 carried out in both 2012 and 2011, according to an annual study of the death penalty […]
read more